Linked Life Data

9696923

Source:http://linkedlifedata.com/resource/pubmed/id/9696923

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1998-10-1
pubmed:abstractText
Difficulties in anxiety treatment is emphasized by benzodiazepine use and misuse. Pathological anxiety threshold can be understood in a dimensional perspective or by large in philosophical considerations. Therapeutic guidelines can be defined on the length of disease or by a categorical and nosological approach. Actually, this one appears more efficient. Numerous studies lead to better selection of psychotropics for each disorders (panic disorder; general anxiety disorder; social phobia; obsessive-compulsive disorder; post-traumatic stress disorder). Therapeutic choice is under others conditions such as length of prescription, severity of the disorders; comorbidity; individual feature to patient. Improvement in therapeutic efficacy needs further studies. Some directions could be: better definition of disorders and their link with personality, appreciation of intensity and chronicity, biological parameters.
pubmed:language
fre
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0013-7006
pubmed:author
pubmed:issnType
Print
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
272-9
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed:articleTitle
[How should drugs for anxiety be prescribed?].
pubmed:affiliation
Université de Paris V, Paris.
pubmed:publicationType
Journal Article, English Abstract, Review